NIIN Output Data
NIIN:
NSN:
Item Name:
BIMATOPROST OPHTHALMIC SOLUTION
Reference/Part Number
Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
---|---|---|---|---|---|---|---|---|
LUMIGAN 0.3 MG/ML 3 FL/3ML | B7001 | A | 5 | 2 | 4 | ZB | ||
LUMIGAN 0.03 MG/ML | 24172 | A | 3 | 2 | 4 | 9Z | ||
1684315 | B6095 | A | 5 | 9 | 6 | ZB |
CAGE Information
Code | Company |
---|---|
24172 | ALLERGAN INC |
B7001 | ALLERGAN NV |
B6095 | ASSOCIATION PHARMACEUTIQUE BELGE |
Characteristics (Decoded)
MRC | Requirements Statement | Clear Text Reply |
---|---|---|
FTLD | FUNCTIONAL DESCRIPTION | IS INDICATED FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE, IOP, IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION WHO ARE INTOLERANT OF OTHER IOP-LOWERING MEDICATIONS OR INSUFFICIENTLY RESPONSIVE TO ANOTHER IOP LOWERING MEDICATION; PROVIDES POWERFUL IOP REDUCTION THAT REMAINS CONSISTENT OVER TIME, BOTH IN NUMBER OF PATIENTS ACHIEVING LOW TARGET PRESSURE AND OVERALL PERCENTAGE REDUCTION |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | LUMIGAN, BIMATOPROST OPHTHALMIC SOLUTION, 0.03 PCT |
FEAT | SPECIAL FEATURES | DOES NOT REQUIRE REFRIGERATION; AVAILABLE IN 2.5 ML AND 5 ML SIZES; HAS BEEN REPORTED TO CAUSE CHANGES TO PIGMENTED TISSUES; INCLUDING INCREASED PIGMENTATION AND GROWTH OF EYELASHES AND INCREASED PIGMENTATION OF THE IRIS AND PERIORBITAL TISSUE, EYELID, CHANGES MAY BE PERMANENT |